Citation Impact
Citing Papers
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study
2003
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
2003 Standout
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Mucins in cancer: function, prognosis and therapy
2009
Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels intoin vitrodiagnostics?
2009
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Surgery Insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer
2007
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Ovarian cancer
2014 Standout
Gestational trophoblastic disease
2010 Standout
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
Effect of Screening on Ovarian Cancer Mortality
2011
Proteomic applications for the early detection of cancer
2003
Detection of glyco‐mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours
2014
Current Management Strategies for Ovarian Cancer
2007
The case for early detection
2003 Nobel
Cancer nanotechnology: opportunities and challenges
2005 Standout
Metagenomic biomarker discovery and explanation
2011 Standout
Cancer genes and the pathways they control
2004 Standout
First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients
2004
Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer
2007
Management of Hepatocellular Carcinoma *
2005 Standout
Recent developments in ovarian cancer screening
2000
Testicular germ-cell tumours in a broader perspective
2005 Standout
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature
2004
Revealing the human mucinome
2022 StandoutNobel
pROC: an open-source package for R and S+ to analyze and compare ROC curves
2011 Standout
Current management of gestational trophoblastic diseases
2008
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
2013
Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation
2002
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression
2007
RECENT ADVANCES IN GESTATIONAL TROPHOBLASTIC DISEASE
1999
A comparison of regression trees, logistic regression, generalized additive models, and multivariate adaptive regression splines for predicting AMI mortality
2006
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by recurrence and fertility rates
2001
True
2000
The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours
2002
Cancer as an evolutionary and ecological process
2006 Standout
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
2009 Standout
Proteomic analysis for the early detection and rational treatment of cancer—realistic hope?
2004
Use of proteomic patterns in serum to identify ovarian cancer
2002 Standout
Cervical cancer
2019 Standout
The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN)
2003
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Ovarian cancer screening in the general population: current status
2001
Ovarian cancer: Epidemiology, biology, and prognostic factors
2000
Advances in Malignant Mesothelioma
2005 Standout
Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection
1995
Cancer of the Ovary
2004 Standout
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
Screening for Thyroid Cancer
2017
Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy
2003
Clinical Proteomics: Revolutionizing Disease Detection and Patient Tailoring Therapy
2004
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Serum Proteomics in Cancer Diagnosis and Management
2004
Current Management Strategies for Ovarian Cancer
2007
Ovarian Cancer
2008
CA125 in Ovarian Cancer
2007
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Screening for Colorectal Cancer
2016 Standout
Fusions of Human Ovarian Carcinoma Cells with Autologous or Allogeneic Dendritic Cells Induce Antitumor Immunity
2000
Mass spectrometry-based proteomics
2003 StandoutNature
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples
2005
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule
2012
Tumor tissue CA125 in ovarian carcinoma patients with normal serum levels
1997
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
A review of feature selection techniques in bioinformatics
2007 Standout
Works of Robert Woolas being referenced
Screening for ovarian cancer: a pilot randomised controlled trial
1999
Role of MR Imaging in the Selection of Patients with Early Cervical Carcinoma for Fertility-preserving Surgery: Initial Experience
1999
The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index
1993
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer
2007
Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study
1996
Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome
1998
Combinations of Multiple Serum Markers Are Superior to Individual Assays for Discriminating Malignant from Benign Pelvic Masses
1995
Combination of Multiple Serum Markers Using an Artificial Neural Network to Improve Specificity in Discriminating Malignant from Benign Pelvic Masses
1999
Immunocytochemical and serological expression of CA 125: a clinicopathological study of 40 malignant ovarian epithelial tumours
1994
Elevation of Multiple Serum Markers in Patients With Stage I Ovarian Cancer
1993
Preoperative Sensitivity and Specificity for Early-Stage Ovarian Cancer When Combining Cancer Antigen CA-125II, CA 15-3, CA 72-4, and Macrophage Colony-Stimulating Factor Using Mixtures of Multivariate Normal Distributions
2004
Influence of Chemotherapy for Gestational Trophoblastic Disease on Subsequent Pregnancy Outcome
1999